Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs WYETH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA WYETH DISHMAN PHARMA/
WYETH
 
P/E (TTM) x 30.0 27.7 108.2% View Chart
P/BV x 3.3 11.3 29.7% View Chart
Dividend Yield % 0.7 10.9 6.1%  

Financials

 DISHMAN PHARMA   WYETH
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
WYETH
Mar-14
DISHMAN PHARMA/
WYETH
5-Yr Chart
Click to enlarge
High Rs3741,065 35.2%   
Low Rs129553 23.3%   
Sales per share (Unadj.) Rs197.0289.5 68.1%  
Earnings per share (Unadj.) Rs21.238.7 54.8%  
Cash flow per share (Unadj.) Rs34.739.9 87.0%  
Dividends per share (Unadj.) Rs2.00145.00 1.4%  
Avg Dividend yield %0.817.9 4.4%  
Book value per share (Unadj.) Rs179.9118.5 151.8%  
Shares outstanding (eoy) m80.7022.72 355.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.8 45.7%   
Avg P/E ratio x11.920.9 56.8%  
P/CF ratio (eoy) x7.320.3 35.8%  
Price / Book Value ratio x1.46.8 20.5%  
Dividend payout %9.4374.7 2.5%   
Avg Mkt Cap Rs m20,30718,381 110.5%   
No. of employees `000NANA-   
Total wages/salary Rs m5,355359 1,493.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,8986,577 241.7%  
Other income Rs m265347 76.4%   
Total revenues Rs m16,1636,925 233.4%   
Gross profit Rs m4,1031,023 401.0%  
Depreciation Rs m1,09127 3,983.2%   
Interest Rs m9444 21,512.5%   
Profit before tax Rs m2,3341,339 174.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624460 135.7%   
Profit after tax Rs m1,710879 194.5%  
Gross profit margin %25.815.6 165.9%  
Effective tax rate %26.734.3 77.8%   
Net profit margin %10.813.4 80.5%  
BALANCE SHEET DATA
Current assets Rs m11,0183,964 277.9%   
Current liabilities Rs m9,5172,081 457.3%   
Net working cap to sales %9.428.6 33.0%  
Current ratio x1.21.9 60.8%  
Inventory Days Days5735 162.5%  
Debtors Days Days3278 1.3%  
Net fixed assets Rs m18,787878 2,140.1%   
Share capital Rs m161227 71.0%   
"Free" reserves Rs m14,3542,466 582.2%   
Net worth Rs m14,5162,693 539.0%   
Long term debt Rs m4,18925 16,744.2%   
Total assets Rs m29,8054,842 615.6%  
Interest coverage x3.5306.0 1.1%   
Debt to equity ratio x0.30 3,106.4%  
Sales to assets ratio x0.51.4 39.3%   
Return on assets %8.918.2 48.8%  
Return on equity %11.832.6 36.1%  
Return on capital %17.549.4 35.5%  
Exports to sales %24.90.1 21,553.3%   
Imports to sales %3.734.7 10.8%   
Exports (fob) Rs m3,9568 52,123.8%   
Imports (cif) Rs m5942,281 26.1%   
Fx inflow Rs m4,9528 65,065.7%   
Fx outflow Rs m6972,298 30.3%   
Net fx Rs m4,255-2,291 -185.7%   
CASH FLOW
From Operations Rs m2,7861,188 234.5%  
From Investments Rs m-1,529287 -533.0%  
From Financial Activity Rs m-941-4,296 21.9%  
Net Cashflow Rs m317-2,821 -11.2%  

Share Holding

Indian Promoters % 61.4 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 23.0 18.4 124.9%  
FIIs % 12.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 48.9 79.0%  
Shareholders   52,291 25,706 203.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs WYETH

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs WYETH Share Price Performance

Period Dishman Pharma WYETH S&P BSE HEALTHCARE
1-Day 2.87% -2.27% 1.18%
1-Month -2.45% 18.58% -0.75%
1-Year 96.38% 69.59% 61.82%
3-Year CAGR 89.34% 15.36% 18.16%
5-Year CAGR 38.20% 8.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the WYETH share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of WYETH the stake stands at 51.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of WYETH.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

WYETH paid Rs 145.0, and its dividend payout ratio stood at 374.7%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of WYETH.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.